Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$1.73 - $2.98 $60 - $104
-35 Reduced 11.86%
260 $0
Q1 2024

Apr 25, 2024

BUY
$0.64 - $1.72 $188 - $507
295 New
295 $0
Q3 2023

Nov 01, 2023

SELL
$0.6 - $0.88 $7 - $11
-13 Reduced 13.13%
86 $0
Q2 2023

Aug 04, 2023

BUY
$0.68 - $1.01 $67 - $99
99 New
99 $0
Q2 2022

Aug 03, 2022

SELL
$1.33 - $2.95 $305 - $678
-230 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$1.91 - $3.23 $1,302 - $2,202
-682 Reduced 74.78%
230 $0
Q4 2021

Feb 23, 2022

SELL
$2.82 - $4.79 $52,251 - $88,753
-18,529 Reduced 95.31%
912 $2,000
Q3 2021

Oct 28, 2021

BUY
$4.43 - $6.29 $16,386 - $23,266
3,699 Added 23.5%
19,441 $122,000
Q2 2021

Aug 12, 2021

BUY
$2.92 - $6.5 $45,966 - $102,323
15,742 New
15,742 $94,000

Others Institutions Holding ENTX

About Entera Bio Ltd.


  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $65.1M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.